Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

SSL Expert Dr. Bernhard Stapp Joins Board of Aledia

Published: Monday, May 27, 2013
Last Updated: Monday, May 27, 2013
Bookmark and Share
Former OSRAM general manager and CTO has played key role in industry’s evolution, will aid Aledia’s move towards industrialization.

Aledia has announced that solid-state lighting (SSL) industry veteran Dr. Bernhard Stapp has joined its board of directors.

Stapp brings more than a dozen years of executive experience in LED lighting technologies to Aledia, most recently in senior management positions at OSRAM, a global leader in SSL manufacturing and marketing.

As general manager and senior vice president of OSRAM AG’s SSL unit, Stapp was responsible for the company’s professional LED and OLED business.

Earlier, as SSL vice president and general manager at OSRAM Opto Semiconductors, he launched and managed the general-lighting LED business and oversaw launch of the world’s first OLED lighting products.

Prior to that, Stapp was vice president and CTO of the semiconductor company, where he oversaw global LED, laser and OLED R&D.

Earlier in his career, he held a variety of management positions in Siemens AG’s Corporate Technology division.

“Aledia’s mission is to bring fundamental change to the world’s lighting markets by making LED technology substantially more affordable and more versatile, with better performance and fewer limitations,” said Giorgio Anania, Aledia’s co-founder, president and CEO.

Anania continued, “Bernhard has been a key player at the heart of the global LED industry since its inception, and also has an outstanding technical background. His unique perspective on this industry’s future will be invaluable as Aledia moves into the next stage of its evolution.”

WireLED®, Aledia’s unique 3D microwire GaN-on-silicon technology, was developed at the CEA-Leti nanotech research institute in Grenoble.

It addresses the basic technical and economic challenges facing LED lighting by allowing production of LEDs on inexpensive industry-standard 200mm silicon wafers using standard semiconductor processes and tools.

“Aledia’s technology is, quite simply, a breakthrough for the entire LED sector,” said Stapp. “It can meet the industry’s critical requirement for cost-reduction, while using far simpler production processes and much less material than conventional approaches. I am very excited about the opportunity to join this team.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Flu Vaccine May Reduce Risk of Death For Type 2 Diabetes Patients
Researchers at Imperial College London have suggested that the vaccine may have substantial benefits for patients with long-term conditions.
Flu Vaccine May Reduce Death Risk of Type 2 Diabetes
New research suggests that a new flu vaccine may reduce probability of type 2 diabetes patients being hospitalised with stroke and heart failure.
Disrupting Tumour-Promotion in Humans
Researchers have modified an existing protein to represses a specific cancer-promoting ‘message’ within cells.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Vaccine Strategy Targets Multiple Influenza Viruses
Scientists have identified vaccine-induced antibodies that can neutralize strains of influenza virus that infect humans.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Structure of Cold Virus Solved
Researchers have identified the structure of an elusive cold virus linked to child asthma and respiratory infections, providing the foundation for treating the virus.
'Poison Pill' Fed to Deadly Virus
Researchers have created a genetic modification within a virus (with funny name), rendering it unable to replicate, mutate or cause illness.
World First Alzheimer's Vaccine Breakthrough
Researchers have made a breakthrough discovery towards an effective vaccine for Alzheimer's by targeting associated proteins.
Immunotherapy Drug Combo Targets Cancer
Mayo Clinic researchers identify potential immunotherapy drug combination that shows therapeutic effects against advanced and metastatic cancers.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!